Sunil Healthcare Share Price Today | Stock Price & Sunil Healthcare Share Screener
As of October 5, 2026, the live Sunil Healthcare share price (NSE: SUNLOC) is ₹68.00 on NSE and ₹67.00 on BSE, down 3.00% from the previous close, with shares trading between ₹66.01 and ₹73.90 in today's trading session, and a 52-week range of ₹68.00–₹80.76. Check SUNLOC 52-week chart for the annual price range and momentum. Use the Sunil Healthcare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Sunil Healthcare opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹20 and net income of ₹2, with EBITDA of ₹2, an operating margin of 9.0% and a profit margin of 10.0%.
Sunil Healthcare Share Price Chart
Track the current stock price of Sunil Healthcare with an interactive chart. Analyse SUNLOC share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Sunil Healthcare stock quote in one place.
The quote of ₹68.00 sits between the 52-week low of ₹68.00 and the 52-week high of ₹80.76, and the latest session moved -3.00% from the previous close.
Sunil Healthcare Company Profile - Fundamental Screener
Screen Sunil Healthcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SUNLOC shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE671C01016.
Company Details
Classification
Identifiers and Leadership
Sunil Healthcare Balance Sheet Screener
Screen SUNLOC balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹165, up from ₹162 in 2025.
Latest statistics put total assets at ₹165 and shareholder funds at ₹70, with a leverage ratio of 1.17.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 165 | 162 | 159 | 121 | 110 | 121 | 130 | 138 | 142 | 119 |
| Current Assets | 74 | 65 | 63 | 48 | 35 | 49 | 59 | 66 | 69 | 57 |
| Fixed Assets | 86 | 94 | 87 | 70 | 70 | 70 | 70 | 69 | 71 | 60 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 29 | 32 | 33 | 19 | 20 | 23 | 19 | 17 | 26 | 19 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | 70 | 67 | 68 | 56 | 50 | 44 | 45 | 47 | 47 | 43 |
| Share Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves & Surplus | 59 | 57 | 58 | 46 | 40 | 34 | 34 | 37 | 37 | 33 |
Sunil Healthcare Income Statement Screener - Profit & Revenue Analysis
Screen Sunil Healthcare income statement and profit fundamentals. Analyze SUNLOC quarterly results. Sunil Healthcare reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Mar, revenue was ₹20 and net profit was ₹2, equal to earnings per unit of ₹0.57, at an operating margin of 9%.
In that period expenses were ₹18, interest cost ₹2 and tax ₹-3. The next period listed, 2026-Jun, shows revenue of ₹19 and net profit of ₹1.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||||
| Revenue | 20 | 19 | 22 | 24 | 24 | 22 | 22 | 22 | 20 | 21 | 22 | 24 | 24 | 26 | 33 |
| Expenses | 18 | 16 | 18 | 19 | 20 | 18 | 19 | 19 | 18 | 18 | 19 | 22 | 23 | 23 | 25 |
Operating Costs and Margins | |||||||||||||||
| EBITDA | 2 | 3 | 4 | 4 | 4 | 4 | 3 | 2 | 3 | 3 | 4 | 2 | 1 | 3 | 8 |
| Operating Profit % | 9.00% | 15.00% | 14.00% | 14.00% | 17.00% | 17.00% | 13.00% | 10.00% | 11.00% | 13.00% | 13.00% | 4.00% | 5.00% | -3.00% | 23.00% |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Interest | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
Profit and Earnings | |||||||||||||||
| Profit Before Tax | -1 | 0 | 0 | 1 | 1 | 1 | 0 | -1 | -1 | 0 | 1 | -1 | -2 | 0 | 6 |
| Tax | -3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| Net Profit | 2 | 1 | 0 | 1 | 1 | 1 | 0 | -1 | -1 | -1 | 0 | -1 | -1 | 0 | 4 |
| EPS | 0.57 | 0.45 | 0.35 | 0.89 | 0.97 | 0.57 | 0.15 | -0.67 | -0.53 | -0.53 | 0.44 | -0.63 | -1.07 | -0.20 | 3.91 |
Sunil Healthcare Cash Flow Screener - Liquidity Fundamentals
Screen SUNLOC cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹22.
Over the same period, investing activities used ₹3 and financing activities used ₹19.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | 22 | 12 | -15 | 8 | 23 | 17 | 4 | 15 | 6 | 11 |
| Investing Activities | -3 | -8 | -10 | -3 | -4 | -11 | -3 | -3 | -17 | -13 |
Financing and Net Cash | ||||||||||
| Financing Activities | -19 | -4 | 25 | -4 | -19 | -6 | -2 | -12 | 11 | 2 |
| Net Cash Flow | 0 | 0 | -1 | 0 | 0 | -1 | 0 | 0 | -1 | 0 |
Sunil Healthcare Shareholding Pattern Screener
See Sunil Healthcare shareholding pattern with promoter, FII, and DII holdings. Check Sunil Healthcare promoter holding and ownership changes for SUNLOC on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 73.53%, foreign institutions 0.00%, domestic institutions 0.10% and the public 17.84%, spread across 6,364 shareholders.
The shareholder count was 6,364 in 2026-Mar, compared with 6,310 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 73.53% | 73.53% | 73.53% | 73.53% | 73.53% | 73.53% | 73.53% | 73.53% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.10% | 0.10% | 0.10% | 0.10% | 0.10% | 0.10% | 0.10% | 0.10% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 17.84% | 17.89% | 17.85% | 17.84% | 17.85% | 17.85% | 17.68% | 17.79% |
| Other Holding | 8.53% | 8.48% | 8.52% | 8.52% | 8.52% | 8.52% | 8.69% | 8.58% |
| Shareholder Count | 6,364 | 6,310 | 6,541 | 6,475 | 6,430 | 6,399 | 6,858 | 6,594 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Sunil Healthcare. Sunil Healthcare dividend yield can be compared with peers and other stocks in the market.
Sunil Healthcare Stock Index Membership - Nifty & Sensex
See which indices include Sunil Healthcare stock. Check SUNLOC index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Sunil Healthcare Market Events Screener - Corporate Actions
Get Sunil Healthcare corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Sunil Healthcare stock events that may affect SUNLOC share price, along with derivatives, futures and options activity and sector gainers.
11 corporate actions are listed, the most recent entry being Annual General Meeting dated September 28, 2026, with a record date of September 28, 2026.
It is followed by Quarterly Result Announcement dated August 13, 2026 and Quarterly Result Announcement dated May 29, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-28 | 2026-09-28 | Annual General Meeting | NA | -1.27% |
| 2026-08-13 | 2026-08-13 | Quarterly Result Announcement | NA | 1.28% |
| 2026-05-29 | 2026-05-29 | Quarterly Result Announcement | NA | 8.22% |
| 2026-02-06 | 2026-02-06 | Quarterly Result Announcement | NA | 8.65% |
| 2025-11-04 | 2025-11-04 | Quarterly Result Announcement | NA | 3.85% |
| 2025-09-29 | 2025-09-29 | Annual General Meeting | NA | -3.12% |
| 2025-07-30 | 2025-07-30 | Quarterly Result Announcement | NA | -1.57% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | -12.18% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | 1.99% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | -5.75% |
| 2024-09-30 | 2024-09-30 | Annual General Meeting | NA | -5.39% |
Sunil Healthcare Competitors Screener - Peer Stocks Comparison
Screen SUNLOC competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 427,010 | 35.84 | 61,674 | 12.69% | 11,565 | 33.78 |
| Divis Laboratories | 244,125 | 84.36 | 11,067 | 13.95% | 2,568 | 49.73 |
| Torrent Pharmaceuticals | 181,512 | 84.01 | 13,886 | 20.34% | 2,138 | 41.48 |
| Zydus Life Science | 113,616 | 24.88 | 27,658 | 17.64% | 5,026 | 46.18 |
| Cipla | 107,890 | 32.42 | 29,045 | 2.24% | 3,870 | 32.87 |
| Laurus Labs | 106,517 | 98.56 | 6,868 | 22.01% | 890 | 56.11 |
| Mankind Pharma | 102,394 | 50.48 | 14,636 | 14.85% | 1,938 | 55.53 |
| Dr Reddys Laboratories | 100,412 | 31.47 | 35,059 | 3.90% | 4,158 | 52.91 |
| Aurobindo Pharma | 96,370 | 25.97 | 34,145 | 5.56% | 3,503 | 49.89 |
| Lupin | 91,961 | 16.71 | 29,039 | 26.75% | 5,356 | 29.12 |
Sunil Healthcare Company Announcements - News & Reports Screener
Screen SUNLOC latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated .
The next most recent announcements are dated September 30, 2026 and September 29, 2026.
| Date | Update | Actions |
|---|---|---|
| Announcement under Regulation 30 (LODR)-Credit Rating | - | |
| 2026-09-30 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-09-29 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-09-26 | Closure of Trading Window | - |
| 2026-09-14 | Intimation Of Book Closure For The Purpose Of 52Nd AGM And Cut Off Date For Remote-Evoting/E-Voting | - |
| 2026-09-03 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-02 | Reg. 34 (1) Annual Report. | - |
| 2026-09-02 | Notice Of 52Nd Annual General Meeting Of The Company/Remote E-Voting Facility/E-Voting Facility And Other Information | - |
| 2026-08-21 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-13 | Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th August 2026 | - |
| 2026-08-13 | Approved Un-Audited Financial Results For The 1St Quarter Of FY 2026-27 Ended On 30.06.2026 | - |
| 2026-07-31 | Board Meeting Intimation for Intimation Of The Board Meeting Scheduled To Be Held On 13.08.2026 Pursuant To Regulation 29 Read With Regulation 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |
| 2026-07-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-30 | Special Window For Transfer And Dematerialisation (Demat) Of Physical Securities | - |
| 2026-06-26 | Closure of Trading Window | - |
| 2026-05-31 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-30 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-29 | Approved Audited Financial Results (Standalone And Consolidated) For The Quarter/Year Ended March 31 2026 | - |
| 2026-05-29 | Board Meeting Outcome for Outcome Of The 269Th Board Meeting Of The Company Held On 29.05.2026. | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹68.00, within a 52-week range of ₹68.00 to ₹80.76. The P/E ratio is 20.20 and the P/B ratio is 1.35, with earnings per unit of ₹3.91. Market capitalisation stands at ₹69.73 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.